Gastric Cancer Diagnostic Procedure Market Scope And Analysis

  • Report Code : TIPRE00029842
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 398
Buy Now

Gastric Cancer Diagnostic Procedure Market Analysis by 2031

Buy Now

Gastric Cancer Diagnostic Procedure Market Report Gastric Cancer Diagnostic Procedure Market Size and Share Gastric Cancer Diagnostic Procedure Market Scope and Analysis

Gastric Cancer Diagnostic Procedure Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.31 Billion
Market Size by 2028 US$ 1.91 Billion
Global CAGR (2022 - 2028) 6.5%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Healthcare Provider
  • Diagnostic Laboratories
  • Hospitals
  • Cancer Research Institutes
  • Oncology Specialty Clinics
By Symptom Type
  • Symptomatic and Asymptomatic
By Body Fluid
  • Blood
  • Urine
  • Saliva
  • Stomach Wash/Gastric Juice
  • Tissue
By Procedure
  • Endoscopic Procedures
  • Biopsy & Tissue Tests
  • Lab Tests
  • In-Vitro Diagnostic Tests
  • Imaging Tests
  • Molecular Diagnostics
  • Multiplexing Molecular Diagnostics & Immunoassays
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Atlas Link Biotech Co Ltd
  • Bio Rad Laboratories Inc
  • MiRXES Pte Ltd
  • Agilent Technologies Inc
  • F Hoffmann La Roche Ltd
  • bioMerieux SA
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Vela Diagnostics Holding Pte Ltd